RecruitingPhase 1 / Phase 2NCT07226986
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Sponsor: Novartis Pharmaceuticals
El Paso, TX · +3 more sites